Article
Long-term RCC survivors do not respond to cytokines
Orlando, FL-Most long-term survivors of metastatic renal cellcarcinoma do not achieve a response to cytokine treatment, according toresults of a pooled analysis by French researchers. Their findings suggesta lack of association between initial tumor regression on cytokine treatmentand long-term survival, except for the few patients who achieve completeregression.
Related Videos
Andrew Armstrong, MD, previews key prostate cancer data at ASCO 2025
BLUES trial: Silicone stents may improve patient care
Roshan Patel, MD, on the impact of restricted irrigation on PCNL outcomes
Targeted Therapy in mHSPC: Effects of Mutation Absence
Real-World Outcomes With Nadofaragene in BCG-Unresponsive NMIBC
An Overview of Nogapendekin Alfa Inbakicept for High-Risk, BCG-Unresponsive NMIBC
Treatment Strategies for Symptomatic Bone Metastases in mHSPC
Jason Scovell, MD, on clinical utility of IsoPSA across racial groups
Jared S. Winoker, MD, discusses real-world study of CVAC 2.0 for kidney stones
Jim Hu, MD, on urinary continence recovery across RARP techniques
Related Content
